Beta Bionics raises 2025 revenue guidance to $96.5M and projects Q4 gross margin improvement amid pharmacy channel expansion
Earnings Call Insights: Beta Bionics, Inc. (BBNX) Q3 2025 Management View CEO Sean Saint opened the call by highlighting "strong performance in the third quarter" and updated annual projections for 2025. He cited record new patient starts and increased...
Seeking Alpha